In-Hyun Park, Ph.D. - Publications

2005 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Cell Biology

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.


Year Citation  Score
2021 Tanaka Y, Park IH. Regional specification and complementation with non-neuroectodermal cells in human brain organoids. Journal of Molecular Medicine (Berlin, Germany). PMID 33651139 DOI: 10.1007/s00109-021-02051-9  0.4
2021 Kim J, Sullivan GJ, Park IH. How well do brain organoids capture your brain? Iscience. 24: 102063. PMID 33554067 DOI: 10.1016/j.isci.2021.102063  0.36
2020 Xiang Y, Cakir B, Park IH. Generation of Regionally Specified Human Brain Organoids Resembling Thalamus Development. Star Protocols. 1. PMID 33103124 DOI: 10.1016/j.xpro.2019.100001  0.36
2020 Wang K, Zhang H, He Y, Jiang Q, Tanaka Y, Park IH, Pober JS, Min W, Zhou HJ. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314586. PMID 32640906 DOI: 10.1161/ATVBAHA.120.314586  0.4
2020 Xiang Y, Cakir B, Park IH. Deconstructing and reconstructing the human brain with regionally specified brain organoids. Seminars in Cell & Developmental Biology. PMID 32553582 DOI: 10.1016/j.semcdb.2020.05.023  0.36
2020 Xiang Y, Tanaka Y, Patterson B, Hwang SM, Hysolli E, Cakir B, Kim KY, Wang W, Kang YJ, Clement EM, Zhong M, Lee SH, Cho YS, Patra P, Sullivan GJ, ... ... Park IH, et al. Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons. Molecular Cell. PMID 32526163 DOI: 10.1016/j.molcel.2020.05.016  0.4
2020 Tanaka Y, Cakir B, Xiang Y, Sullivan GJ, Park IH. Synthetic Analyses of Single-Cell Transcriptomes from Multiple Brain Organoids and Fetal Brain. Cell Reports. 30: 1682-1689.e3. PMID 32049002 DOI: 10.1016/j.celrep.2020.01.038  0.4
2019 Cakir B, Xiang Y, Tanaka Y, Kural MH, Parent M, Kang YJ, Chapeton K, Patterson B, Yuan Y, He CS, Raredon MSB, Dengelegi J, Kim KY, Sun P, Zhong M, ... ... Park IH, et al. Engineering of human brain organoids with a functional vascular-like system. Nature Methods. PMID 31591580 DOI: 10.1038/s41592-019-0586-5  0.4
2019 Kang YJ, Clement EM, Sumsky SL, Xiang Y, Park IH, Santaniello S, Greenfield LJ, Garcia-Rill E, Smith BN, Lee SH. The critical role of persistent sodium current in hippocampal gamma oscillations. Neuropharmacology. 107787. PMID 31550457 DOI: 10.1016/j.neuropharm.2019.107787  0.32
2019 Belair C, Sim S, Kim KY, Tanaka Y, Park IH, Wolin SL. The RNA exosome nuclease complex regulates human embryonic stem cell differentiation. The Journal of Cell Biology. PMID 31308215 DOI: 10.1083/jcb.201811148  0.4
2019 Xiang Y, Tanaka Y, Cakir B, Patterson B, Kim KY, Sun P, Kang YJ, Zhong M, Liu X, Patra P, Lee SH, Weissman SM, Park IH. hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids. Cell Stem Cell. PMID 30799279 DOI: 10.1016/j.stem.2018.12.015  0.4
2018 Xiang Y, Yoshiaki T, Patterson B, Cakir B, Kim KY, Cho YS, Park IH. Generation and Fusion of Human Cortical and Medial Ganglionic Eminence Brain Organoids. Current Protocols in Stem Cell Biology. 47. PMID 30854156 DOI: 10.1002/cpsc.61  0.36
2018 Patterson B, Tanaka Y, Park IH. Correction to: New Advances in Human X Chromosome Status from a Developmental and Stem Cell Biology. Tissue Engineering and Regenerative Medicine. 15: 125. PMID 30603540 DOI: 10.1007/s13770-017-0111-9  0.4
2018 Kim KY, Tanaka Y, Su J, Cakir B, Xiang Y, Patterson B, Ding J, Jung YW, Kim JH, Hysolli E, Lee H, Dajani R, Kim J, Zhong M, Lee JH, ... Park IH, et al. Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a. Nature Communications. 9: 2583. PMID 29968706 DOI: 10.1038/s41467-018-04818-0  0.56
2017 Patterson B, Tanaka Y, Park IH. New Advances in Human X chromosome status from a Developmental and Stem Cell Biology. Tissue Engineering and Regenerative Medicine. 14: 643-652. PMID 29276809 DOI: 10.1007/s13770-017-0096-4  0.4
2017 Xiang Y, Tanaka Y, Patterson B, Kang YJ, Govindaiah G, Roselaar N, Cakir B, Kim KY, Lombroso AP, Hwang SM, Zhong M, Stanley EG, Elefanty AG, Naegele JR, Lee SH, ... ... Park IH, et al. Fusion of Regionally Specified hPSC-Derived Organoids Models Human Brain Development and Interneuron Migration. Cell Stem Cell. PMID 28757360 DOI: 10.1016/j.stem.2017.07.007  0.4
2017 Siller R, Dufour E, Lycke M, Wilmut I, Jung YW, Park IH, Sullivan GJ. Development of an inducible platform for intercellular protein delivery. International Journal of Pharmaceutics. PMID 28254654 DOI: 10.1016/j.ijpharm.2017.02.067  0.36
2017 Han L, Wu HJ, Zhu H, Kim KY, Marjani SL, Riester M, Euskirchen G, Zi X, Yang J, Han J, Snyder M, Park IH, Irizarry R, Weissman SM, Michor F, et al. Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells. Nucleic Acids Research. PMID 28126923 DOI: 10.1093/nar/gkx026  0.32
2016 Yang J, Tanaka Y, Seay M, Li Z, Jin J, Garmire LX, Zhu X, Taylor A, Li W, Euskirchen G, Halene S, Kluger Y, Snyder MP, Park IH, Pan X, et al. Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors. Nucleic Acids Research. PMID 28003475 DOI: 10.1093/nar/gkw1214  0.4
2016 Lee S, Park C, Han JW, Kim JY, Cho K, Kim EJ, Kim S, Lee SJ, Oh SY, Tanaka Y, Park IH, An HJ, Shin CM, Sharma S, Yoon YS. Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2. Circulation Research. PMID 28003219 DOI: 10.1161/CIRCRESAHA.116.309833  0.4
2016 Liu R, Kim KY, Jung YW, Park IH. Dnmt1 regulates the myogenic lineage specification of muscle stem cells. Scientific Reports. 6: 35355. PMID 27752090 DOI: 10.1038/srep35355  0.36
2016 Hysolli E, Tanaka Y, Su J, Kim KY, Zhong T, Janknecht R, Zhou XL, Geng L, Qiu C, Pan X, Jung YW, Cheng J, Lu J, Zhong M, Weissman SM, ... Park IH, et al. Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family. Stem Cell Reports. PMID 27373925 DOI: 10.1016/j.stemcr.2016.05.014  0.52
2015 Greer CB, Tanaka Y, Kim YJ, Xie P, Zhang MQ, Park IH, Kim TH. Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery. Cell Reports. PMID 26549458 DOI: 10.1016/j.celrep.2015.10.013  0.4
2015 Lee BK, Shen W, Lee J, Rhee C, Chung H, Kim KY, Park IH, Kim J. Tgif1 Counterbalances the Activity of Core Pluripotency Factors in Mouse Embryonic Stem Cells. Cell Reports. PMID 26411691 DOI: 10.1016/j.celrep.2015.08.067  0.36
2015 Xiang Y, Kim KY, Gelernter J, Park IH, Zhang H. Ethanol Upregulates NMDA Receptor Subunit Gene Expression in Human Embryonic Stem Cell-Derived Cortical Neurons. Plos One. 10: e0134907. PMID 26266540 DOI: 10.1371/journal.pone.0134907  0.4
2015 Tanaka Y, Hysolli E, Su J, Xiang Y, Kim KY, Zhong M, Li Y, Heydari K, Euskirchen G, Snyder MP, Pan X, Weissman SM, Park IH. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming. Stem Cell Reports. 4: 1125-39. PMID 26004630 DOI: 10.1016/j.stemcr.2015.04.009  0.52
2014 Kim KY, Hysolli E, Tanaka Y, Wang B, Jung YW, Pan X, Weissman SM, Park IH. X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports. 2: 896-909. PMID 24936474 DOI: 10.1016/j.stemcr.2014.04.003  0.52
2014 Jeon I, Choi C, Lee N, Im W, Kim M, Oh SH, Park IH, Kim HS, Song J. In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. International Journal of Stem Cells. 7: 43-7. PMID 24921027 DOI: 10.15283/ijsc.2014.7.1.43  0.52
2014 Tanaka Y, Kim KY, Zhong M, Pan X, Weissman SM, Park IH. Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Human Molecular Genetics. 23: 1045-55. PMID 24129406 DOI: 10.1093/hmg/ddt500  0.4
2013 Cheng J, Guo S, Chen S, Mastriano SJ, Liu C, D'Alessio AC, Hysolli E, Guo Y, Yao H, Megyola CM, Li D, Liu J, Pan W, Roden CA, Zhou XL, ... ... Park IH, et al. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cell Reports. 5: 471-81. PMID 24120864 DOI: 10.1016/j.celrep.2013.08.050  0.52
2013 Larimore J, Ryder PV, Kim KY, Ambrose LA, Chapleau C, Calfa G, Gross C, Bassell GJ, Pozzo-Miller L, Smith Y, Talbot K, Park IH, Faundez V. MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. Plos One. 8: e65069. PMID 23750231 DOI: 10.1371/journal.pone.0065069  0.52
2013 Dajani R, Koo SE, Sullivan GJ, Park IH. Investigation of Rett syndrome using pluripotent stem cells. Journal of Cellular Biochemistry. 114: 2446-53. PMID 23744605 DOI: 10.1002/jcb.24597  0.36
2013 Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, et al. Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Science Translational Medicine. 5: 188le2. PMID 23740897 DOI: 10.1126/scitranslmed.3005065  0.52
2013 Lee JB, Werbowetski-Ogilvie TE, Lee JH, McIntyre BA, Schnerch A, Hong SH, Park IH, Daley GQ, Bernstein ID, Bhatia M. Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Blood. 122: 1162-73. PMID 23733337 DOI: 10.1182/blood-2012-12-471649  0.52
2013 Tulpule A, Kelley JM, Lensch MW, McPherson J, Park IH, Hartung O, Nakamura T, Schlaeger TM, Shimamura A, Daley GQ. Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell. 12: 727-36. PMID 23602541 DOI: 10.1016/j.stem.2013.04.002  0.52
2013 Lee ST, Gong SP, Yum KE, Lee EJ, Lee CH, Choi JH, Kim DY, Han H, Kim KS, Hysolli E, Ahn JY, Park IH, Han JY, Jeong JW, Lim JM. Transformation of somatic cells into stem cell-like cells under a stromal niche. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2644-56. PMID 23580613 DOI: 10.1096/fj.12-223065  0.56
2013 Siller R, Greenhough S, Park IH, Sullivan GJ. Modelling human disease with pluripotent stem cells. Current Gene Therapy. 13: 99-110. PMID 23444871  0.32
2013 Pan X, Durrett RE, Zhu H, Tanaka Y, Li Y, Zi X, Marjani SL, Euskirchen G, Ma C, Lamotte RH, Park IH, Snyder MP, Mason CE, Weissman SM. Two methods for full-length RNA sequencing for low quantities of cells and single cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 594-9. PMID 23267071 DOI: 10.1073/pnas.1217322109  0.52
2013 Chang DJ, Lee N, Park IH, Choi C, Jeon I, Kwon J, Oh SH, Shin DA, Do JT, Lee DR, Lee H, Moon H, Hong KS, Daley GQ, Song J. Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplantation. 22: 1427-40. PMID 23044029 DOI: 10.3727/096368912X657314  0.52
2012 Tanaka Y, Chung L, Park IH. Impact of retrotransposons in pluripotent stem cells. Molecules and Cells. 34: 509-16. PMID 23135636 DOI: 10.1007/s10059-012-0242-8  0.52
2012 Maclean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 17567-72. PMID 23045682 DOI: 10.1073/pnas.1215468109  0.52
2012 Ge X, Ren Y, Bartulos O, Lee MY, Yue Z, Kim KY, Li W, Amos PJ, Bozkulak EC, Iyer A, Zheng W, Zhao H, Martin KA, Kotton DN, Tellides G, ... Park IH, et al. Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation. 126: 1695-704. PMID 22914687 DOI: 10.1161/CIRCULATIONAHA.112.116996  0.52
2012 Kim KY, Jung YW, Sullivan GJ, Chung L, Park IH. Cellular reprogramming: a novel tool for investigating autism spectrum disorders. Trends in Molecular Medicine. 18: 463-71. PMID 22771169 DOI: 10.1016/j.molmed.2012.06.002  0.52
2012 Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, ... ... Park IH, et al. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. The Biochemical Journal. 446: 359-71. PMID 22694310 DOI: 10.1042/BJ20111495  0.52
2012 Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, et al. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 30: 2054-62. PMID 22628015 DOI: 10.1002/stem.1135  0.52
2012 Loh YH, Yang JC, De Los Angeles A, Guo C, Cherry A, Rossi DJ, Park IH, Daley GQ. Excision of a viral reprogramming cassette by delivery of synthetic Cre mRNA. Current Protocols in Stem Cell Biology. Unit4A.5. PMID 22605648 DOI: 10.1002/9780470151808.sc04a05s21  0.52
2012 Kim KY, Hysolli E, Park IH. Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP. Journal of Visualized Experiments : Jove. PMID 22491226 DOI: 10.3791/3804  0.36
2012 Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proceedings of the National Academy of Sciences of the United States of America. 109: 5803-8. PMID 22451909 DOI: 10.1073/pnas.1202922109  0.52
2012 Zhou XL, Sullivan GJ, Sun P, Park IH. Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Archives of Pharmacal Research. 35: 261-9. PMID 22370780 DOI: 10.1007/s12272-012-0206-8  0.32
2012 Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Current Opinion in Neurology. 25: 125-30. PMID 22357218 DOI: 10.1097/WCO.0b013e3283518226  0.52
2012 Hysolli E, Jung YW, Tanaka Y, Kim KY, Park IH. The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome. Cell Cycle (Georgetown, Tex.). 11: 229-35. PMID 22234239 DOI: 10.4161/cc.11.2.18998  0.52
2012 Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, et al. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells (Stem Cells (2012) 30 (2054-2062)) Stem Cells. 30: 2602. DOI: 10.1002/stem.1245  0.52
2011 Ballabeni A, Park IH, Zhao R, Wang W, Lerou PH, Daley GQ, Kirschner MW. Cell cycle adaptations of embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 19252-7. PMID 22084091 DOI: 10.1073/pnas.1116794108  0.52
2011 Kim KY, Hysolli E, Park IH. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America. 108: 14169-74. PMID 21807996 DOI: 10.1073/pnas.1018979108  0.36
2011 Jang J, Kang HC, Kim HS, Kim JY, Huh YJ, Kim DS, Yoo JE, Lee JA, Lim B, Lee J, Yoon TM, Park IH, Hwang DY, Daley GQ, Kim DW. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Annals of Neurology. 70: 402-9. PMID 21721033 DOI: 10.1002/ana.22486  0.52
2011 Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, Yao J, Redenti S, Daley GQ, Young MJ. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. Plos One. 6: e18992. PMID 21559507 DOI: 10.1371/journal.pone.0018992  0.52
2011 Wang A, Tang Z, Park IH, Zhu Y, Patel S, Daley GQ, Li S. Induced pluripotent stem cells for neural tissue engineering. Biomaterials. 32: 5023-32. PMID 21514663 DOI: 10.1016/j.biomaterials.2011.03.070  0.52
2011 Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park IH, Basford C, Wheeler MB, Daley GQ, Elefanty AG, Stanley EG, Keller G. Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development (Cambridge, England). 138: 861-71. PMID 21270052 DOI: 10.1242/dev.055236  0.52
2011 Pessach IM, Ordovas-Montanes J, Zhang SY, Casanova JL, Giliani S, Gennery AR, Al-Herz W, Manos PD, Schlaeger TM, Park IH, Rucci F, Agarwal S, Mostoslavsky G, Daley GQ, Notarangelo LD. Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 127: 1400-7.e4. PMID 21185069 DOI: 10.1016/j.jaci.2010.11.008  0.52
2011 Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology. 85: 43-50. PMID 20962093 DOI: 10.1128/JVI.01774-10  0.52
2010 Neveu P, Kye MJ, Qi S, Buchholz DE, Clegg DO, Sahin M, Park IH, Kim KS, Daley GQ, Kornblum HI, Shraiman BI, Kosik KS. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell. 7: 671-81. PMID 21112562 DOI: 10.1016/j.stem.2010.11.012  0.52
2010 Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nature Genetics. 42: 1113-7. PMID 21057500 DOI: 10.1038/ng.710  0.52
2010 Park IH. Five classic articles in somatic cell reprogramming Yale Journal of Biology and Medicine. 83: 135-137. PMID 20885901  0.52
2010 Gaines P, Liu R, Park IH. Research highlights. Regenerative Medicine. 5: 501-3. PMID 20632853 DOI: 10.2217/rme.10.47  0.32
2010 Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, Huo H, Okuka M, Dos Reis RM, Loewer S, Ng HH, Keefe DL, Goldman FD, Klingelhutz AJ, Liu L, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature. 464: 292-6. PMID 20164838 DOI: 10.1038/nature08792  0.52
2010 Park IH. DYS-HAC-iPS cells: The combination of gene and cell therapy to treat duchenne muscular dystrophy Molecular Therapy. 18: 238-240. PMID 20125163 DOI: 10.1038/mt.2009.303  0.52
2010 Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH, Wagner EF, Keller GM. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood. 115: 2769-76. PMID 20065292 DOI: 10.1182/blood-2009-07-234690  0.52
2010 Sullivan GJ, Hay DC, Park IH, Fletcher J, Hannoun Z, Payne CM, Dalgetty D, Black JR, Ross JA, Samuel K, Wang G, Daley GQ, Lee JH, Church GM, Forbes SJ, et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology (Baltimore, Md.). 51: 329-35. PMID 19877180 DOI: 10.1002/hep.23335  0.36
2009 Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genetics. 41: 1350-3. PMID 19881528 DOI: 10.1038/ng.471  0.52
2009 Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnology. 27: 1033-7. PMID 19826408 DOI: 10.1038/nbt.1580  0.52
2009 Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation. 120: 1513-23. PMID 19786631 DOI: 10.1161/CIRCULATIONAHA.109.868885  0.52
2009 West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH, Sero JE, Zhu H, Perez-Atayde A, Frazier AL, Surani MA, Daley GQ. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature. 460: 909-13. PMID 19578360 DOI: 10.1038/nature08210  0.52
2009 Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou BK, Chen G, Ye Z, Park IH, Daley GQ, Porteus MH, Joung JK, Cheng L. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell. 5: 97-110. PMID 19540188 DOI: 10.1016/j.stem.2009.05.023  0.52
2009 Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature. 459: 1126-30. PMID 19458618 DOI: 10.1038/nature08062  0.52
2009 Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, Daley GQ, Eggan K, Hochedlinger K, Thomson J, Wang W, et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotechnology. 27: 353-60. PMID 19330000 DOI: 10.1038/nbt.1530  0.52
2008 Müller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, Lu C, Park IH, Rao MS, Shamir R, Schwartz PH, Schmidt NO, Loring JF. Regulatory networks define phenotypic classes of human stem cell lines. Nature. 455: 401-5. PMID 18724358 DOI: 10.1038/nature07213  0.52
2008 Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Disease-specific induced pluripotent stem cells. Cell. 134: 877-86. PMID 18691744 DOI: 10.1016/j.cell.2008.07.041  0.52
2008 Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 451: 141-6. PMID 18157115 DOI: 10.1038/nature06534  0.52
2006 West JA, Park IH, Daley GQ, Geijsen N. In vitro generation of germ cells from murine embryonic stem cells. Nature Protocols. 1: 2026-36. PMID 17487192 DOI: 10.1038/nprot.2006.303  0.52
2006 Bachmann RA, Kim JH, Wu AL, Park IH, Chen J. A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. The Journal of Biological Chemistry. 281: 7357-63. PMID 16407298 DOI: 10.1074/jbc.M512218200  0.52
2005 Park IH, Chen J. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. The Journal of Biological Chemistry. 280: 32009-17. PMID 16043480 DOI: 10.1074/jbc.M506120200  1
2005 Park IH, Erbay E, Nuzzi P, Chen J. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Experimental Cell Research. 309: 211-9. PMID 15963500 DOI: 10.1016/j.yexcr.2005.05.017  1
2003 Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. The Journal of Cell Biology. 163: 931-6. PMID 14662739 DOI: 10.1083/jcb.200307158  1
2003 Fang Y, Park IH, Wu AL, Du G, Huang P, Frohman MA, Walker SJ, Brown HA, Chen J. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Current Biology : Cb. 13: 2037-44. PMID 14653992 DOI: 10.1016/j.cub.2003.11.021  0.52
2002 Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. The Journal of Biological Chemistry. 277: 31423-9. PMID 12087098 DOI: 10.1074/jbc.M204080200  1
Show low-probability matches.